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Complex biological products, such as those used to treat various forms of cancer, are
typically produced by mammalian cells in bioreactors. The most important class of such
biological medicines is proteins. These proteins typically bind to sugars (glycans) in a
process known as glycosylation, creating glycoproteins, which are more stable and effective
medicines. The glycans are large polymers that are formed by a long sequence of enzyme
catalysed reactions. This sequence is not always completed, thus leading to a heterogeneous
glycoprotein distribution. A better comprehension of this distribution could lead to more
efficient production of high quality drugs.
To understand how the manufacturing process can affect the extent of glycosylation
of protein, a nonlinear ODE model of glycoprotein production is developed which de-
scribes the bioreactor configuration as well as the protein production and glycosylation
reactions within the cell. The entire system evolves eventually to a stable steady state.
The earlier evolution itself is critical however, as the amount of product produced and its
quality varies over time. The model is considered as two coupled systems: the bioreactor
submodel and the glycosylation submodel. To investigate the early time evolution within
the bioreactor submodel, analytical and numerical properties are derived using matched
asymptotic expansions and a finite difference scheme for a range of initial conditions. This
leads to qualitatively different regimes for aglycosylated protein production, which affect
the glycosylation submodel. The discrete glycoprotein distribution is approximated as
continuous and written as a first order PDE, with good agreement between the discrete
and continuous models. The PDE is found to admit shocks, but the existence of these
shocks is dependent on the early time evolution within the bioreactor submodel and leads
to higher levels of glycosylation at early time. This suggests that changing the bioreactor
configuration can lead to higher quality product at certain points in time.
1 Introduction
While historically the majority of medicines were small molecules, a rapidly increasing
number of new drugs developed by the pharmaceutical industry are protein therapeutics
[8]. Proteins are complex macromolecules which are involved in almost all processes
within cells. Their complexity and specificity of action means that they are able to
produce therapeutic effects that could not be replicated by small molecule drugs. Protein
therapeutics have been used for a number of reasons: to aid drug delivery, as vaccines, and
to treat diseases including cancer, genetic diseases and diseases of the immune system [17].
Additionally there are financial incentives for companies to develop protein therapeutics
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since they typically have a shorter clinical development and approval time than small
molecule drugs, and companies are able to acquire comprehensive patents [19].
The majority of these therapeutic proteins are produced using recombinant DNA
technology. This entails the alteration of the genetic material of a host organism, (typically
the bacterium Escherichia coli, yeast, or mammalian cells) to insert the gene coding
for the protein of interest. The host organism then produces the recombinant protein
alongside the native proteins necessary for usual function. These cells are produced outside
of their natural environment in a bioreactor, where conditions such as temperature, pH
and cell substrate levels are carefully monitored.
However, after the protein is synthesised by the host cell, the molecule is typically
modified in a number of ways before being excreted by the cell. One of the most common of
these post-translational modifications is glycosylation - the process by which carbohydrate
molecules are attached to the protein. There are two kinds of glycosylation, the N-linking of
sugars to asparagine residues, and O-linking of sugars to serine or threonine residues. The
kind and extent of glycosylation seems to influence therapeutic efficacy as well as half-life
in the body [10; 20]. It is therefore important to understand how to produce protein-
based therapeutics with appropriate glycosylation [11]. Unfortunately, the biochemistry
of glycosylation is extremely complex , involving many enzymes, various locations in
the Golgi apparatus and endoplasmic reticulum, and a large number of product variants
[3; 25].
Attempts have been made to model glycosylation as a complex network [14], leading to
elaborate models. Engineering models have embedded glycosylation models into bioreactors
[12; 16; 26], and have substantially improved our understanding of the behaviour of
glycosylation in bioreactors. However, such models contain a large number of parameters,
many of which cannot be measured directly. In this paper we take a different approach.
Using a very simple kinetic model for the stepwise addition of one kind of sugar to a
product, we analyse product formation in terms of quality and quantity in a chemostat.
This gives rise to a set of coupled, nonlinear ordinary differential equations, which are
analysed in detail to explore the influence of a wide range of initial conditions giving
significant variation in quality and quantity distinct from that in steady state. The focus is
on allowing a large number of such sugar additions; we also show that passing to the limit
of a continuous mixture, a tractable partial differential equation (PDE) results. This PDE
is hyperbolic, and admits of the formation of a shock. The condition for shock formation
is established explicitly, and it is shown that selecting initial conditions that generate a
shock results in improved product quality and quantity, relative to the product obtained
at steady state. This unusual result suggests that the trade-off between quantity and
quality is more subtle than previously believed. In the discussion, some suggestions are
presented on how to extend the present analysis to more complex models of glycosylation.
2 Model Development
Our model considers the interaction between cell mass and substrate in a chemostat: where
substrate is fed into the reactor at a constant rate, and a fraction of the bioreactor culture
is washed out continuously. The reactor is stirred and therefore spatially homogeneous.
All other important parameters, such as temperature or pH are held constant. The specific
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growth rate of the cells increases with substrate concentration, following Monod kinetics.
The rate of production of aglycosylated protein per cell again increases with substrate
concentration according to Michaelis-Menten kinetics.
We then consider glycosylation as the enzyme catalysed stepwise addition of sugars to
the protein. The concentration of other reactants necessary for glycosylation is assumed
to not be a limiting factor and hence these reactions follow Michaelis-Menten kinetics.
This process leads to differing glycoprotein variants, which are denoted p∗j , where j is
the number of sugars attached to the protein molecule and the asterisk denotes the
dimensional quantity. The maximum number of sugars that can be attached is n, and so
the final variant is p∗n.
In the following the bioreactor parameters are the dilution rate D∗ and the concentration
of the substrate feed s∗f . For the cell mass, r
∗
x is the maximal specific growth rate, K
∗
x
is the half-saturation constant, k∗d is the cell death rate and Y
∗
x is the yield coefficient.
The parameters concerning protein production are the maximal production rate r∗0 , the
half saturation constant K∗0 and the yield coefficient Y
∗
0 . The reaction that leads to the
formation of the glycoprotein variant p∗j , where 0 ≤ j ≤ n, has the following parameters:
r∗j is the maximal reaction rate, K
∗
j the half-saturation constant and Y
∗
j is the yield
coefficient.
Thus the full dimensional model is as follows. It is first to solve for the cell mass x∗,
the substrate s∗ and the aglycosylated protein p0 using
dx∗
dt∗
=
r∗xs
∗x∗
K∗x + s∗
− (D∗ + k∗d)x∗, (2.1 a)
ds∗
dt∗
= D∗(s∗f − s∗)−
1
Y ∗x
(
r∗xs
∗x∗
K∗x + s∗
)
− 1
Y ∗0
(
r∗0s
∗x∗
K∗0 + s∗
)
, (2.1 b)
dp∗0
dt∗
=
r∗0s
∗x∗
K∗0 + s∗
− 1
Y ∗1
(
r∗1p
∗
0
K∗1 + p
∗
0
)
−D∗p∗0, (2.1 c)
and then for 1 ≤ j ≤ n to solve for the intermediate glycoprotein variants p∗j as well as
the final glycoprotein variant p∗n using
dp∗j
dt∗
=
r∗j p
∗
j−1
K∗j + p
∗
j−1
− 1
Y ∗j+1
(
r∗j+1p
∗
j
K∗j+1 + p
∗
j
)
−D∗p∗j , (2.1 d)
dp∗n
dt∗
=
r∗np
∗
n−1
K∗n + p∗n−1
−D∗p∗n. (2.1 e)
The initial conditions are
x∗(0) = x∗0, (2.2 a)
s∗(0) = s∗0, (2.2 b)
p∗j (0) = 0 for all j, (2.2 c)
where x∗0 and s
∗
0 are given constants from the operating conditions of the bioreactor. To
reduce the considerable number of parameters in the system, non-dimensionalisation is
now performed by setting
(t∗, x∗, s∗, p∗j ) = (
t
D∗
,K∗xY
∗
x x,K
∗
xs,K
∗
j+1pj). (2.3)
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While most of the values are intrinsic parameters of the system, we introduce K∗n+1 as a
half-saturation constant for a theoretical reaction where the substrate is p∗n, and K
∗
n+1 is
used as a typical value for p∗n. (It would be expected to be in line with K
∗
n.) We also set
rx =
r∗x
D∗
, (2.4 a)
kd =
k∗d
D∗
, (2.4 b)
sf =
s∗f
K∗x
, (2.4 c)
r0 =
r∗0K
∗
xY
∗
x
K1D∗
, (2.4 d)
K0 =
K∗0
K∗x
, (2.4 e)
Y0 =
K∗xY
∗
0
K∗1
, (2.4 f )
rj =
r∗j
K∗j+1D∗
for all j >= 1, (2.4 g)
Yj =
K∗j Y
∗
j
K∗j+1
for all j >= 1. (2.4 h)
The initial values x(0) = x0 and s(0) = s0 are thus as follows from (2.2),
s0 =
s∗0
K∗x
, (2.5 a)
x0 =
x∗0
K∗xY ∗x
. (2.5 b)
From (2.1) we now have our non-dimensionalised model:
dx
dt
=
rxsx
1 + s
− (1 + kd)x, (2.6 a)
ds
dt
= sf − s− rxsx
1 + s
− 1
Y0
(
r0sx
K0 + s
)
, (2.6 b)
dp0
dt
=
r0sx
K0 + s
− 1
Y1
r1p0
1 + p0
− p0, (2.6 c)
and for 1 ≤ j ≤ n− 1
dpj
dt
=
rjpj−1
1 + pj−1
− 1
Yj+1
rj+1pj
1 + pj
− pj , (2.6 d)
dpn
dt
=
rnpn−1
1 + pn−1
− pn. (2.6 e)
The values of the parameters in our system will now be considered, with the values
used throughout the paper detailed in Table 1. We have relative freedom for the initial
conditions in our bioreactor s∗0 and x
∗
0, and these will be varied to characterise different
qualitative behaviour within the bioreactor. The experimenter also has choice when it
comes to setting s∗f and D
∗. The cell growth and product production parameters r∗x,
A simplified model of glycoprotein production within cell culture 5
Table 1. The dimensionless parameter values used for all model runs, unless indicated
otherwise.
Parameter Value
n 20
rx 2
kd 0.1
sf 10
r0 1
K0 1
Y0 0.2
rj 1
Yj 1
K∗x, Y
∗
x , r
∗
0 , K
∗
0 and Y
∗
0 vary widely between cell lines. Generally k
∗
d in (2.4 b) is a small
number, as cell death is slow in comparison to other cellular processes when the reactor
is operating at ideal conditions [24].
The number of glycoprotein variants, here denoted as n, considered in previous models
varies from 33 to 5685, depending on their level of detail [12; 16; 26]. Here we set n = 20,
but the results are qualitatively similar for other values of n. The stoichiometry of each
glycosylation reaction sets Y ∗j = 1. Determining the parameter values for the glycosylation
reactions is a complex task [27]. Therefore for most of the paper we will assume that
all glycosylation reactions are catalysed by the same enzyme, and thus r∗j and K
∗
j are
constant for j > 0. Whilst there are multiple enzymes involved in the full reaction network,
each enzyme catalyses many reactions [12], and thus this a reasonable starting point to
understand this effect of each enzyme.
Since this model is generic and does not aim to produce results for a particular cell line,
a set of representative dimensionless parameters each of order 1 is used, as illustrated in
table 1. However, the advantage of the present analytical approach is that the effect of
parameter changes can be deduced without running a large parameter sweep.
The whole model can be divided quite naturally into two coupled submodels - the
cell-substrate interaction consisting of x, s and p0, and the glycosylation system consisting
of pj with 0 ≤ j ≤ n. The behaviour at finite time t turns out to be important throughout,
as the extent of the glycosylation, and thus the quality of the product, varies in time.
3 Cell substrate interaction
In this section of the paper, we consider the submodel for the bioreactor, to determine
the production of unglycosylated protein. This consists of the governing equations for the
cell mass x (2.6 a), substrate s (2.6 b) and unglycosylated protein p0 (2.6 c).
Part of the qualitative behaviour of the system will be examined, by determining the
existence and properties of the steady states. The time evolution of the system is then
examined first by solving the equations numerically. Second, by considering the relative
initial conditions for cell mass and substrate to be asymptotically large or small, analytical
solutions for whole time evolution are found.
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3.1 Steady states and stability
There are two possible steady states for this system. The first is the trivial zero cell case,
where x = 0, s = sf and p0 = 0. If there are no cells, due to complete cell death or a zero
initial condition, no protein can be produced and thus the system consists only of the
substrate entering the reactor. If certain constraints on parameter values hold, there is a
second steady state as follows:
se =
1 + kd
rx − (1 + kd) , (3.1)
xe =
sf − se
rx
se
1+se
+ r0Y0
se
K0+se
, (3.2)
p0,e =
1
2
 r0sexe
K0 + se
− r1
Y1
− 1 +
√(
r0sexe
K0 + se
− r1
Y1
− 1
)2
+ 4
r0sexe
K0 + se
 . (3.3)
Since all variables are non-negative, the other quadratic root for p0,e is neglected. For the
same reason, this steady state will exist only if the conditions rx > 1 + kd, sf > se and
r0sexe
K0+se
> r1Y1 + 1 hold. It is well established that this steady state is stable if it exists since
the reactor is a chemostat [24]. The zero cell steady state is undesirable as no protein is
produced, so from this point we assume that the conditions on the parameters hold and
therefore the system has a unique nontrivial stable steady state to which it can evolve.
3.2 Time evolution
The equations were solved numerically using a finite difference scheme, to investigate
the time evolution of the system. In addition to the equation parameters, the initial
conditions for the cell mass, x0 and substrate, s0 have large effects on the early time
behaviour of the system. This is illustrated in figure 1: the phase plane for the cell mass x
and the substrate s on a log scale, with varying initial conditions for both x and s. Linear
stability is visible for all trajectories close to the steady states, but there are clearly several
regimes of qualitatively different behaviour, depending on the initial conditions. The
three principal regimes are highlighted, and the full time-dependent numerical solutions
for x, s and p0 are given for regime A in figure 2(a), for regime B in figure 3 and for
regime C in figure 4. In the next section these are explained and analytical solutions are
found using matched asymptotic expansions. This asymptotic analysis allow us to clearly
understand the most important processes within our system at each time scale, and thus
clearly differentiate between each regime in figure 1. Similar methods have been used
extensively when modelling biological systems [4; 9; 18]
We consider a typical initial-value parameter  1 and then explore the major details
of the evolution where at least one of the initial conditions x0 and s0 is either O() or
O( 1 ). Since these initial conditions affect the protein production at early time, and thus
the extent of glycosylation, changing these is found to lead to differing quality levels
thoroughout time.
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Figure 1. The phase plane for the cell mass x and the substrate s trajectories, displayed on
a log scale. Three trajectories are highlighted as representative of three different regimes. The
black dots are plotted at evenly spaced time intervals to illustrate the progress through time.
3.3 Main examples of evolution
The three principal regimes A, B and C are explored in the following subsections. Table
1 gives parameter values used throughout. These are supplemented by analysis which
exposes interesting multi-scaling present for t of O(1), cf [21–23] in other fields, and
provides fresh insight and clarity as to how early time behaviour can affect quantity and
quality.
3.3.1 Regime A
First, the behaviour of solutions is explored when the initial values s0 and x0 are order
1
 . This is represented as regime A in the top right hand corner of figure 1, where the
trajectories move downwards, initially curving to the right, before turning a sharp corner
to move diagonally towards the steady state. The full numerical solutions for x, s and p0
are illustrated in figure 2(a). While the solution for s seems to turn a sharp corner, the
short time scales expanded upon in this section fully explain this behaviour. For these
initial conditions, the denominators appearing in (2.6 a - 2.6 c) simplify and the effects of
the sf and r1 contributions become secondary; so the governing equations of the model
(2.6) become linearised. The main response arises first on the O(1) time scale where t = t¯
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with the expansions
x =
1

x¯+ · · · , (3.4 a)
s =
1

s¯+ · · · , (3.4 b)
p0 =
1

p¯0 + · · · , (3.4 c)
holding then. Here the size of p0 is dictated by the protein production term involving sx
over the O(1) time scale; earlier p0 is smaller of course due to the initial condition. At
leading order, the governing equation for the cell mass x (2.6 a) thus becomes
dx¯
dt
= (rx − 1− kd)x¯. (3.5)
Hence x is independent of s initially, as substrate is not limiting cell growth. As described
in section 3.1, for the non-trivial steady state to exist, rx > 1 + kd. Hence x¯ grows
exponentially and has the form
x¯ = x¯0e
(rx−1−kd)t. (3.6)
The substrate s¯ is governed by
ds¯
dt
= −
(
rx +
r0
Y0
)
x¯− s¯, (3.7)
and hence the solution for s¯ is a sum of exponential decay and negative exponential
growth.
s¯ = (s¯0 + γx¯0)e
−t − γx¯0e(rx−1−kd)t (3.8)
where γ =
rx+
r0
Y0
rx−kd . The substrate is therefore rapidly depleted due to the large cell mass.
The governing equation for the unglycosylated protein p¯0 is
dp¯0
dt
= r0x¯− p¯0 (3.9)
which can be solved to give
p¯0 =
r0
rx − kd
(
e(rx−1−kd)t − e−t
)
. (3.10)
Hence the amount of protein in the bioreactor increases rapidly initially because there is
a large quantity of cell mass and the substrate does not limit protein production.
These analytical solutions are compared to the numerical solutions in figure 2(b) and
show good agreement initially, with the solutions diverging as the initial assumptions
(3.4) fail. The solution for s¯ is the leading factor for the expansions ceasing to hold, as it
decreases to zero at a finite time t = t0 (contrasting with x¯ and p¯0 which remain O(1)
then). This leads to a new expansion, beginning around the time t0 when s¯ in effect
decreases to O(), so s becomes O(1) and the influence of the denominators in (2.6 a -
2.6 c) comes into play as the substrate begins to limit cell growth and protein production.
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Figure 2. Numerical and analytical solutions for cell mass x, substrate s and protein p0 in
regime A, where x0 = 50 and s0 = 50. We take  = 0.02. The solid curves represent numerical
solutions and the dotted curves analytical solutions.
(a) illustrates the full time evolution to steady state.
(b) illustrates the first timescale from the expansions (3.4) with the solutions (3.6), (3.8) and
(3.10). Here x¯0 = s¯0 = 1.
(c) illustrates the second timescale from the expansions (3.11) with the solutions (3.13), (3.16)
and (3.19). Here t0 = 0.13, sˆ0 = 2, xˆ0 = 1.1, pˆ0,0 = 0.117.
(d) illustrates the third timescale from the expansions (3.21) with the solution (3.23). Here tˇ0 = 1,
sˇ0 = 1, xˇ0 = 1.094, pˇ0,0 = 0.123.
(e) illustrates the fourth timescale, with the expansions (3.25) and the solution (3.28). Here
x˜0 = 1.094, s˜0 = 1.31, p˜0 = 0.123.
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Thus:
t = t0 + tˆ, (3.11 a)
x =
1

(xˆ0 + xˆ) + · · · , (3.11 b)
s = sˆ+ · · · , (3.11 c)
p0 =
1

(pˆ0,0 + pˆ0) + · · · , (3.11 d)
with the hatted variables to be found. The governing equations then become
dsˆ
dtˆ
= −rx xˆ0sˆ
1 + sˆ
− r0
Y0
xˆ0sˆ
K0 + sˆ
, (3.12 a)
dxˆ
dtˆ
=
rxxˆ0sˆ
1 + sˆ
− (1 + kd)xˆ0, (3.12 b)
dpˆ0
dtˆ
=
r0xˆ0sˆ
1 + sˆ
− pˆ0,0. (3.12 c)
For simplicity we set K0 = 1 here, although this assumption could be relaxed if required.
We then set β = rx +
r0
Y0
and integrate to obtain an implicit relation between tˆ and sˆ,
−βxˆ0tˆ = sˆ− sˆ0 + log
(
sˆ
sˆ0
)
. (3.13)
Explicit features are found for limiting values of tˆ. For large negative tˆ (matching back to
the previous stage) we have
sˆ ∼ sˆ0 − βxˆ0sˆ0
1 + sˆ0
tˆ, (3.14)
and for large positive tˆ,
sˆ ∼ sˆ0e−βxˆ0 tˆ; (3.15)
so sˆ→ 0 as tˆ→∞. Meanwhile the governing equation for xˆ gives the relation
xˆ = −xˆ0
[
rx
β
(sˆ− sˆ0) + (1 + kd)tˆ
]
. (3.16)
At large negative tˆ,
xˆ ∼ xˆ0
[
rxxˆ0sˆ0
1 + sˆ0
− (1 + kd)
]
tˆ, (3.17)
which is increasing if we ensure this phase is begun early enough. At large positive tˆ,
xˆ ∼ rxxˆ0sˆ0
β
− (1 + kd) tˆ, (3.18)
and so xˆ has a maximum in this time range and then begins to decrease due to the small
values of sˆ at this point. This can be clearly seen in figure 1, as the trajectories turn
significantly in the bottom right hand corner. Similarly we can integrate our equation for
pˆ0,0 to obtain
pˆ0 = −r0xˆ0
β
(sˆ− sˆ0)− pˆ0,0tˆ (3.19)
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which mimics the behaviour of xˆ. These analytical solutions are again compared with
numerical solutions in figure 2(c).
Once more, our assumptions break down due to the exponential decay of sˆ at large
time, and another expansion begins at the time tˇ0 when
sˇ0 ∼ sˆ0e−βxˆ0 tˆ. (3.20)
With this logarithmic time shift the time scale and expansions are:
t = t0 + (F tˇ0 + tˇ), (3.21 a)
x =
1

(xˇ0 + xˇ+ · · · ), (3.21 b)
s =
1

(2sˇ+ · · · ), (3.21 c)
p0 =
1

(pˇ0,0 + pˇ0 + · · · ), (3.21 d)
where F = − 1βxˆ0 log( sˇ0sˆ0 ) is a large positive constant. To leading order, our governing
equations become
dsˇ
dtˇ
= sf − βxˆ0sˇ, (3.22 a)
dxˇ
dtˇ
= 0, (3.22 b)
dpˇ0
dtˇ
= 0, (3.22 c)
and so xˇ and pˇ0 remain at their initial values xˇ0 and ˇp0,0 respectively, while
sˇ =
1
βxˆ0
[
sf − (sf − βxˆ0sˇ0)eβxˆ0 tˇ
]
, (3.23)
all of which are illustrated and compared to the numerical solutions in figure 2(d).
As tˇ → ∞, the exponential term in sˇ becomes small, and therefore we define a new
time scale which begins when
sf − βxˆ0sˇ0
βxˆ0
eβxˆ0 tˇ ∼ . (3.24)
Here we let tˇ = Gt˜0, where G = − 1βxˆ0sˇ0 log(
βxˆ0
sf−βxˆ0 ) and t˜0 is an arbitrary constant of
order 1. Thus the final time scale and expansions are as follows:
t = t0 + (F tˇ0 +Gt˜0) + t˜, (3.25 a)
x =
1

x˜+ · · · , (3.25 b)
s = s˜+ · · · , (3.25 c)
p0 =
1

p˜0 + · · · , (3.25 d)
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with
s˜(0) =
sf
βxˆ0
, (3.26 a)
x˜(0) = xˇ0, (3.26 b)
p˜0(0) = pˇ0,0. (3.26 c)
To leading order the governing equations become
0 = sf − βx˜s˜, (3.27 a)
dx˜
dt˜
= −(1 + kd)x˜, (3.27 b)
dp˜0
dt˜
= −p˜0, (3.27 c)
and so we have the following pure exponential solutions:
s˜ =
sf
βx˜0
e(1+kd)t˜, (3.28 a)
x˜ = xˇ0e
−(1+kd)t˜, (3.28 b)
p˜0 = pˇ0,0e
−t˜. (3.28 c)
This regime is again clearly visible as the straight diagonal line in figure 1. Additionally,
these analytical solutions are compared with the numerical ones in figure 2(e). In logarith-
mic time our assumptions fail, but the qualitative behaviour does not markedly change
as the solutions display linear stability.
While explicit solutions have only been given for the case where x0 ∼ 1 , s0 ∼ 1 , similar
or related qualitative behaviour is seen in figure 1 for other initial conditions. This can be
explained with reference to regime A. First, if x0 ∼ 1 and s0 ∼ 1 , the solution is very
similar to regime A illustrated before. However, the first stage represented by the barred
variables in (3.4) is slightly different, with (3.7) modified to be
ds
dt
= −s (3.29)
and hence s falls more slowly. On the other hand, since x is growing exponentially in
(3.6), the x term re-enters (3.29) and hence the solution continues as previously described,
but the exponential growth lasts for longer, as is visible in figure 1. The solution for p0
also remains unmodified.
Similarly, if x0 ∼ 1 and s0 ∼ 1, the solution is identical in form to regime A, except that
we begin with the hatted variables and (3.11) and (3.12 c). Again, if we have x0 ∼ 1 and
s0 ∼ , the solutions for cell mass and substrate are the same as for regime A, beginning
with the checked variables in (3.21) and (3.22), moving on to the tilde variables (3.25)
and (3.27). However, the solution for p0 in the tilde timescale will clearly be different, as
(3.25 d) will not hold due to the zero initial condition. Instead we introduce
p0 = ˜˜p0 (3.30)
and hence (3.28 c) is replaced by
d ˜˜p0
dt˜
= r0x˜s˜− r1
Y1
˜˜p0
1 + ˜˜p0
− ˜˜p0, (3.31)
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which can be solved implicitly.
3.3.2 Regime B
We now describe the behaviour shown by regime B in figure 1, which occurs when the
initial values x0 ∼  and s0 ∼  are both small. The full time evolution is shown in figure
3. These initial conditions and the forcing due to sf in (2.6 b) imply that initially we have
an O(1) time scale and the following expansions:
t = T, (3.32 a)
s = S + · · · , (3.32 b)
x = X + · · · , (3.32 c)
p0 = P0 + · · · , (3.32 d)
so that the governing equation (2.6 a), (2.6 b) and (2.6 c) become
dS
dT
= sf − S, (3.33 a)
dX
dT
=
rxSX
1 + S
− (1 + kd)X, (3.33 b)
dP0
dT
=
r0SX
K0 + S
− ( r1
Y1
+ 1)P0. (3.33 c)
Thus the expressions
S = sf + (S0 − sf )e−T , (3.34 a)
X = X0e
(rx−1−kd)T
[
(1 + sf )e
T + (S0 − sf)
1 + S0
] −rx
1+sf
, (3.34 b)
P0 =
∫
r0XS
1+S e
(
r1
Y1
+1)T dT
e(
r1
Y1
+1)T
, (3.34 c)
describe the solutions at this stage. Since rx−1−kd is always positive, exponential growth
dominates the expression for x. The numerical and analytical solutions are compared
in figure 3, where it is clear that the expansions break down in logarithmic time, and
the cell growth term rxxs1+s re-enters the s equation. This is where the trajectory begins
moving downwards towards linear stability in the phase plane in figure 1.
3.3.3 Regime C
We now consider the top left hand corner of the phase plane in figure 1, where s(0) is
large of order 1 and x(0) is small of order . The full evolution in time is shown in figure 4.
Guided by the initial values and the influence of interactive terms we set the expansions
x = x`+ · · · , (3.35 a)
s =
1

s`+ · · · , (3.35 b)
p0 = p`0 + · · · , (3.35 c)
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Figure 3. Numerical and analytical solutions for cell mass x, substrate s and protein p0 in
Regime B, where x0 = 0.01 and s0 = 01. The solid curves represent the numerical solutions for
the full time evolution. The dashed curves represents the analytical solution as given by the
expansions in (3.32) and the solutions in (3.34). Here  = 0.01, X0 = 1, S0 = 1
for t of O(1) and hence our governing equations become
ds`
dt
= −s`, (3.36 a)
dx`
dt
= (rx − 1− kd)x`, (3.36 b)
dp`0
dt
= r0x`− ( r1
Y1
+ 1)p`0. (3.36 c)
The solutions are
s` = s`0e
−t, (3.37 a)
x` = x`0e
(rx−1−kd)t, (3.37 b)
p`0 =
r0
rx − kd + r1Y1
(
e(rx−1−kd)t − e−(
r1
Y1
+1)t
)
. (3.37 c)
Hence the dominant process for substrate s is washout, leading to exponential decay.
Cell mass x is growing at its maximum rate, but is tempered by washout and cell death,
leading to exponential growth. The protein production mimics cell growth, although
glycosylation and washout slow the growth. This behaviour is clearly visible in figure 1
in the top left hand corner. Again, a comparison with numerical solutions is shown in
figure 4. The expansions cease to hold as s becomes order 1, and the cell growth and
protein production terms are no longer linear. However the time evolution continues in a
qualitatively similar way, before approaching linear stability.
By considering regimes A, B and C, the qualitative and quantitative behaviour of
the entire phase plane can thus be explained. It can be seen that changing the initial
conditions for cell mass x and substrate s (which can be done by the experimenter) has
a large effect on the quantity of protein in the bioreactor at early time. In particular,
the protein production in regime A, shown in figure 2(a), is markedly different from the
protein production in regime B, shown in figure 3. In the latter half of the paper, we
demonstrate how these two regimes have very different glycosylation patterns at early
time, which has implications for the quality of the product.
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Figure 4. Numerical and analytical solutions for cell mass x, substrate s and protein p0 in
Regime C, where x0 = 0.01 and s0 = 100. The solid curves represent the numerical solutions
for the full time evolution. The dashed curves represents the analytical solution as given by the
expansions in (3.35) and the solutions in (3.37). Here  = 0.01, x`0 = 1, s`0 = 1.
4 Glycosylation submodel
We now turn our attention to the glycosylation submodel, in order to determine the shape
of the dynamic glycosylation distribution pj(t). First the steady glycosylation distribution
will be examined, before considering the time evolution. The governing equations of this
subsystem consist of (2.6 c), (2.6 d) and (2.6 e) as stated earlier. Again, the number of
glycoprotein variants, n, is assumed to be relatively large, and the reaction rates rj and
yield coefficients Yj are assumed constant for all j.
4.1 Steady states
The steady states for each variant, where the time derivatives are equal to zero, depend
only on the steady state of the previous variant, because each glycosylation reaction is
stepwise. Since all quantities are nonnegative, we can see from (2.6 d) that each equation
has one nonnegative root:
pj =
1
2
 rjpj−1
1 + pj−1
− rj+1
Yj+1
− 1 +
√(
rjpj−1
1 + pj−1
− rj+1
Yj+1
− 1
)2
+ 4
rjpj−1
1 + pj−1
 . (4.1)
From (2.6 e), the terminal glycoprotein has a steady state
pn =
rnpn−1
1 + pn−1
. (4.2)
We repeat that the evolution in t however is of most concern, as by adjusting the
configuration of the bioreactor via the initial conditions for cell mass x and substrate
s, the glycosylation distribution can be manipulated. Thus the dynamic behaviour is
examined in detail, to identify points at which the quality of the product is favourable.
5 A continuum glycosylation model
To further explore the dynamic glycoform distribution, we consider a partial differential
equation model for the glycosylation system. The number of glycoform variants, n, is
relatively large [16], and therefore we look to approximate the glycoform distribution
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investigated in section 3.1 as continuous. We replace the discrete glycosylation index j
with a continuous variable z that represents the extent of glycosylation, and obtain
pj(t) = p(t, z). (5.1)
Here the integer points of the continuous variable z correspond to the discrete indices
j. However we now allow intermediate reactions where z takes non-integer values. Each
glycosylation reaction is thus seen as increasing the extent of glycosylation by δz, i.e. each
reaction is denoted by
p(t, z)→ p(t, z + δz). (5.2)
The nondimensional parameters rj and Yj are also modified. Since rj is the maximal
reaction rate in the jth reaction, the equivalent rate for the reaction represented in (5.2)
is R(z)δz . The yield coefficient is defined from the non-dimensionalisation in equations 2.4
Yj =
K∗j Y
∗
j
K∗j+1
. (5.3)
We have assumed perfect conversion and hence Y ∗j = 1. If the Monod constants Kj vary
smoothly, then we model them by a smooth function κ(z). Hence we take
Yj =
κ(z)
κ(z + δz)
. (5.4)
If δz is sufficiently small then we may write
1
Yj
= 1− κ
′(z)
κ(z)
δz. (5.5)
We also introduce the following function for our reaction terms,
f(p(t, z), R(z)) =
R(z)p(t, z)
1 + p(t, z)
. (5.6)
The equation (2.6 d) for each intermediate glycoform variant becomes now
∂p
∂t
(t, z) =
1
δz
f(p(t, z− δz), R(z))− 1
δz
f(p(t, z), R(z+ δz))(1− κ
′(z)
κ(z)
δz)− p(t, z). (5.7)
We then take the limit as δz → 0 and obtain the first order PDE
∂p
∂t
(t, z) = − df
dz
+R(z)
κ′(z)
κ(z)
f(z)− p(t, z) (5.8)
for the system. The function f(z) allows this derivation to hold for many kinetic forms
[1; 2]. However, for our case with Michaelis-Menten kinetics given by (5.6) we obtain
∂p
∂t
+
R(z)
(1 + p)2
∂p
∂z
= (R(z)
κ′(z)
κ(z)
−R′(z)) p
1 + p
− p, (5.9)
with a zero initial condition at t = 0 and a dynamic boundary condition at z = 0 taken
from the solution for p0 from the bioreactor submodel; thus
p(z, 0) = 0, (5.10)
p(0, t) = p0(t). (5.11)
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Figure 5. A comparison of the steady-state glycoform distribution for the discrete and continuum
models. The round markers are the discrete solutions for the distribution, the sequence pj at
steady state. The left plot shows solutions for different values of r = R and the right plot shows
the distribution where p0 = 0.1, 0.2 and 0.3 for r = R = 10.
For our analysis, we focus on the case mentioned previously where the parameter values
do not vary between reactions and hence R(z) and κ(z) are constant, giving
∂p
∂t
+
R
(1 + p)2
∂p
∂z
= −p. (5.12)
The final glycoform variant pn(t) has an equation of a different form but can be found
from the continuum model as
pn(t) =
∫ ∞
n
p(t, z) dz (5.13)
from all the glycoform variants.
5.1 Steady State analysis
We can obtain the steady state p = ps, to compare with the discrete system, by taking
∂p
∂t = 0 in (5.12) which yields
dps
dz
=
−ps(ps + 1)2
R
. (5.14)
From this, certain properties of the glycoform distribution are immediately clear. First,
the distribution is always monotonically decreasing. Second, higher values of R (and r for
the discrete solutions) lead to a flatter distribution, and finally, higher values of p0 lead
to a steeper distribution. These attributes, as well as a comparison between the steady
state results for the discrete and continuum models, are shown in figure 5. A close fit is
obtained for values of r above 10, and the agreement is still reasonable at r = 2.
We now perform a linear stability analysis on this steady solution, by considering the
evolution of a small perturbation to the steady state:
p(z, t) = ps(z) +B(z)e
−αt + · · · (5.15)
where α > 0 and B(z) 1. Substituting this solution into the original PDE (5.12) and
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linearising, to first order the PDE becomes, on rearrangement,
dB
B
=
[
(α− 1)(ps + 1)
2
R
+
2p′s
(ps + 1)
]
dz. (5.16)
Here ′ denotes differentiation with respect to z. However, from (5.14) we have
(ps + 1)
2
R
dz =
dps
−ps (5.17)
since p′sdz = dps and so (5.16) gives
dB
B
=
[
1− α
ps
+
2
ps + 1
]
dps. (5.18)
Integrating this from z = 0, we obtain
B(z)
B(0)
=
(
ps(z)
p0,s
)1−α(
ps(z) + 1
p0,z + 1
)2
. (5.19)
If we impose α > 1, the perturbation decays in z and thus the steady state is stable as
expected.
5.2 Dynamic Solution
Since the equation (5.12) is hyperbolic, it can be solved by the method of characteristics.
Two sets of characteristics are found, one which transmits information from the zero initial
condition and one that transmits information from the dynamic boundary condition, in
the form
dt
1
=
dz
R
(1+p)2
=
dp
−p . (5.20)
We introduce ξ to parametrise the characteristics, as the point at which a characteristic
crosses the t axis where z = 0. Along the characteristics p decays exponentially
p = p0(ξ)e
(ξ−t), (5.21)
from (5.20). However, if the characteristic does not cross the positive t axis, then we
apply the zero initial condition instead of the boundary condition, implying that p = 0
along such characteristics. Hence we obtain the “zero” characteristics:
z = R(t− ξ). (5.22)
By integrating (5.20), the “non-zero” characteristics have the shape
z(t, ξ) = h(p0(ξ)e
(ξ−t))− h(p0(ξ)) (5.23)
where
h(p) = −R
(
log
(
p
p+ 1
)
+
1
p+ 1
)
. (5.24)
The evolution of p0(t) therefore drives the shape of the characteristics. Thus the evolution
of p0, as discussed in section 3.2 is critical to understanding the dynamic glycoform
distribution. Certain p0 trajectories in fact lead to crossed characteristics. This in turn
leads to a discontinuity in p(z) which manifests itself as a shock. In figure 6(a), the initial
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Figure 6. A comparison of the dynamical solutions for the discrete and continuous models. The
left panels represent the discrete solution. The panels on the right show the characteristics, while
the coloured dots give contours of constant p. In (a), the large initial conditions lead to a shock,
whereas in (b), the small initial conditions do not. Here r = R = 10.
conditions correspond qualitatively to regime A in section 3.2 and a shock is present;
whereas in figure 6(b), the initial conditions correspond qualitatively to regime B and a
shock does not occur. In both cases there is also reasonably good agreement with the
discrete case. The conditions determining the occurrence of a shock are investigated
below.
5.3 Shock condition
For a shock to occur, two adjacent characteristics must meet. Hence for small δξ,
z(t, ξ) = z(t, ξ + δξ), (5.25)
and so, from the limit δξ → 0, they will meet if
∂
∂ξ
(z(t, ξ)) = 0, (5.26)
and
(p′0 + p0)e
ξ−th′(p0eξ−t) + p′0h
′(p0) = 0. (5.27)
Thus the condition becomes
p′0 = −
(p0 + 1)
2
(1− eξ−t)(p0(1 + eξ−t) + 2 . (5.28)
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Figure 7. The right panels show the conditions for a shock to form. The solid curves represent
the conditions for a shock to begin at varying values of t. From the bottom to the top, the values
of t are increasing. The dashed curve is the p0 trajectory corresponding to the initial conditions
for x and s. In (a), the large initial conditions mean the trajectory satisfies the conditions for a
shock to form and the circular marker shows the point at which the characteristics first cross.
This marker in the left panel also shows where the shock begins in the (t, z) plane. In (b), the
large initial conditions do not lead to a shock forming.
The condition is used to find the time at which the characteristics first cross, and therefore
when the shock begins. This time is the minimum t for which the condition is satisfied,
which occurs at the most negative value of p′0. The value of ξ at which the minimum of
p′0 occurs gives the leading characteristic into the shock. In figure 7, the shock condition
(5.28) is illustrated with differing values of t for two different sets of initial conditions. In
the right panel of figure 7(a) the trajectory intersects with the shock conditions and thus
the characteristics begin to cross at t = 0.24, as shown by the red circular marker, which
is also shown in the left panel as the point where the characteristics begin. In figure 7(b)
by contrast, the p0 trajectory does not intersect with the shock condition for any time,
and thus the characteristics shown in the left panel do not cross. This shock condition
indicates that a shock will only form if p0 decreases sharply, as occurs in regime A in
section 3.2, but not in regimes B or C.
5.4 Shock position
Since the shock represents a discontinuity, the model needs to be modified to give a
physical solution. The simplest way of doing this is to add a small term including the
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second z derivative, which is only felt close to the shock. This allows us to calculate the
speed of the shock, using say
∂p
∂t
+
R
(1 + p)2
∂p
∂z
= −p+ ∂
2p
∂z2
. (5.29)
The change of variables z − h(t) ≡ z¯, where z = h(t) is the position of the shock, yields
∂p
∂t
− h′(t)∂p
∂z¯
+
R
(1 + p)2
∂p
∂z¯
= −p+ ∂
2p
∂z¯2
, (5.30)
and so in the shock layer, i.e. where z¯ = zˆ, to leading order we have
−h′ ∂p
∂zˆ
+
R
(1 + p)2
∂p
∂zˆ
=
∂2p
∂zˆ2
. (5.31)
We also have conditions at the edge of the shock layer where the solution for p is well
defined:
As zˆ → +∞, p→ p+∞ = p0(ξ + ξshock)eξ+ξshock−t; (5.32)
As zˆ → −∞, p→ p−∞ = p0(ξ − ξshock)eξ−ξshock−t. (5.33)
Additionally, as zˆ → ±∞, ∂p∂zˆ → 0. By integrating (5.31) between +∞ and −∞ we obtain
h′(t) =
R
(1 + p+∞)(1 + p−∞)
(5.34)
which gives the slope of the shock. This is the geometric mean of the slope of the two
characteristics entering the shock. The “height” of the shock is p+∞ − p−∞, which has
a factor of eξ−t and therefore decays exponentially as t → ∞, and hence the shock
dissipates.
Thus when the model has been modified in this way, the discontinuous shock is replaced
by a wave that moves forward in z and dissipates as time progresses. In the left panel of
figure 8(a), this wave is visible in the results for the discrete model. In this case, a shock
has occurred in the corresponding continuous model, due to the rapid decrease in p0 visible
in the right panel. Thus the glycosylation distribution is no longer always monotonically
decreasing, which potentially has impact on the quality of the product. For example, at
t = 0.9, p5 > p0, and hence there is more protein with a higher level of glycosylation. By
contrast, in figure 8(b), a shock has not occurred in the corresponding continuous model
and there is no wave. The glycosylation distribution is always monotonically decreasing,
and thus there is no favourable point with higher levels of glycosylation.
6 Discussion
The glycosylation patterns of therapeutic proteins can be highly heterogeneous, and
controlling this heterogeneity is an important element in maintaining product quality in
the biopharmaceutical industry. Measuring the glycosylation distribution of therapeutic
proteins experimentally is a difficult task, and thus mathematical modelling is a useful tool
to further understanding. The complexity of detailed glycosylation models [12; 13; 16; 26]
has made them difficult to use in process bioreactor models. In the rare cases where
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Figure 8. The left panels show solutions for the dynamic glycosylation distribution pj at
given time points. On the right the aglycosylated protein production p0(t) is shown, with the
timepoints from the left panels also marked. In (a) the large inital conditions lead to a shock in
the continuous model, and this manifests itself as a wave in the discrete model. In (b) the small
initial conditions do not lead to a shock, and so there is no wavelike behaviour in the discrete
model.
complex glycosylation models are used [15], the values of the parameters used are an
important consideration for practical application.
Our focus has been on the detailed analysis of the consequences to the bioreactor
of using a simple glycosylation model. The impact of the initial configuration of the
bioreactor on the aglycosylated protein production is fully understood, as well as the
impact this has on the glycosylation distribution. The simplicity of the model has allowed
us to analyse completely the behaviour of any number of product variants, which led to
the continuous-mixture limit [1; 7], in which a denumerably infinite number of product
variants is considered. This limit has often produced insights that are hard to obtain from
discrete models [2], and that trend has held true in this model. The occurrence of a shock
in the hyperbolic PDE model, as shown in figure 6, predicted non-monotonic product
distributions for certain cases, which also occurred in the discrete analogue with a finite
number of product variants, but would have been much harder to discern.
Also on practical applications, it is not known yet if shock formation for example occurs
in realistic configurations but the shock effect typifies the range where initial conditions
lead to considerable unusual features; these and other features raise interesting possibilities
for experimental study. The usefulness of the approximations involved also rests in their
demonstration that the responses and subtle structures arising during evolution are quite
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different from what is encountered in the steady state, a matter taken up below in terms
of quality and quantity during product formation.
We now detail explicitly how the purposeful creation of a non-monotonic product
distribution generates product of higher quality and quantity than is found at steady
state. The total product quantity is denoted
ptotal(t) =
n∑
j=0
pj(t). (6.1)
The quality of the product is defined in two ways: the mean level of glycosylation
qmean(t) =
∑n
j=0 jpj(t)
ptotal(t)
, (6.2)
and the fraction of product that is glycosylated above a critical level c
qthresh(t) =
∑n
j=c pj(t)
ptotal(t)
. (6.3)
Changing this critical level does not change the qualitative behaviour. Thus, using the
second quality metric, we also define the total amount of good quality product
pqual(t) = ptotal(t)qthresh(t). (6.4)
In figure 9, product quantity and quality are described as a function of time for two
different initial conditions, x0 = s0 = 20, which is similar to regime A (dashed line) and
x0 = s0 = 0.05, which is similar to regime C (solid line); these regimes were previously
discussed in detail in section 3.2. The values shown are those in the bioreactor at the
specific timepoint, but since the reactor is a chemostat these are proportional to those in
the outflow which go on to be processed [24].
The top left panel shows the total product quantity, which evolves as predicted. For
the small initial conditions, as seen in (3.35) ptotal ∼ , and hence the growth to steady
state is slow and monotonic. However, for the large initial conditions detailed in (3.4),
there is initial fast growth, followed by a slower decline towards the steady state. Hence,
the glycoprotein production is larger before the reactor reaches steady state.
However, this also has an impact on product quality in a non-obvious fashion. As
seen in the top right and bottom left panels, with large initial conditions both quality
measures rise quickly to a maximum before dropping to the steady state. Therefore, for a
significant period of time the quality of the glycoprotein is higher. The maximum occurs
because of the shock formation in the equivalent continuous model - the glycosylation
distribution is then not monotonically decreasing, which therefore increases both quality
measures. The bottom right panel shows the total amount of good quality protein, (the
amount glycosylated above the threshold), which again shows a maximum for the large
initial conditions. This quality increase due to difference in bioreactor configuration is
not obvious, and merits further investigation.
One reason we were able to analyse this model fully is its relatively small number
of parameters, which is further reduced by passing to the continuous limit of the PDE.
The results were shown to be quite generally valid, which is very difficult to show for
high-parameter systems, because the number of simulations needed to reveal all the
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Figure 9. The quantity and quality of product formation with two differing initial conditions
in the bioreactor, from the discrete model. Two quality metrics are shown, the mean level of
glycosylation in the top right panel and the proportion above a threshold level of glycosylation in
the bottom left panel. The total good quality glycoprotein in the bottom right panel shows the
amount of protein that is glycosylated above that threshold. There are 20 glycoprotein variants
and the glycosylation threshold is 10. Here rx = 10.
interactions grows exponentially with the number of parameters. A related benefit is
that the parameters of our model could be easily determined from experiment, since it is
clearly not over-parametrised.
A natural extension is to apply the model to other reactor modes, especially the
fed-batch mode that is widely used in therapeutic production. The simple model for cell
growth could also be made more realistic, by accounting for cell heterogeneity. Production
bioreactors, with volumes exceeding 10m3, inevitably are not well-mixed, and have regions
of relatively low oxygen and substrate levels. The state of cells in these regions will also
be different from those in other regions. These model adaptations could be investigated
in future work.
The complex interactions among the product variants, even in this simple kinetic
model, have led to unexpected operating conditions leading to effective productivities
that are quite different from the corresponding steady-state values. Such results have
been discussed in the literature for very different chemical systems [5; 6]. The possibility
that such improved productivity could be attained for more realistic bioreactor modes is
intriguing, and we are studying such generalisations.
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